◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

HomeAll stocks0-9 › 9273

Koa Shoji Holdings Co.,Ltd. (9273) Financial History

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Healthcare · Drug Manufacturers - Specialty & Generic · DATA UPDATED 2026-08-09

Koa Shoji Holdings Co.,Ltd. (9273) operates in the Drug Manufacturers - Specialty & Generic industry and is headquartered in Yokohama, Japan. Its market capitalization is roughly JPY 32 billion.

Koa Shoji Holdings Co.,Ltd., through its subsidiaries, imports and sells active pharmaceutical ingredients (APIs) in Japan. The company is involved in the manufacture and marketing of over-the-counter drugs and pharmacologically active injection.

Interactive charts & full statements →

9273 Revenue & Earnings History — Annual Income Statement

Income statement2025-06-302024-06-302023-06-302022-06-30
Total RevenueJPY 22.1BJPY 22.1BJPY 20.4B
Gross ProfitJPY 6.6BJPY 6.4BJPY 5.9B
Operating Income (EBIT)JPY 4.4BJPY 4.2BJPY 3.8B
Net IncomeJPY 2.9BJPY 2.7BJPY 2.4B

JPY; JPYM / JPYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

9273 Free Cash Flow History

Cash flow2024-06-302023-06-302022-06-30
Dividends Paid(JPY 475M)(JPY 436M)(JPY 395M)

JPY; JPYM / JPYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

9273 Balance Sheet History

Balance sheet2024-06-302023-06-302022-06-30
Total AssetsJPY 32.0BJPY 28.5BJPY 26.2B
Total LiabilitiesJPY 7.0BJPY 7.5BJPY 7.6B

JPY; JPYM / JPYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive 9273 viewer.

Other Companies in Drug Manufacturers - Specialty & Generic

← 9268All “0-9” companies9274 →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.